Renal hemodynamic responses to intrarenal infusion of ligands for the putative angiotensin IV receptor in anesthetized rats

Journal of Cardiovascular Pharmacology

Volumn 34, Issue 2, 1999, Pages 206-211

  Fitzgerald, Sharyn M ^a   Evans, Roger G ^b,c   Bergström, Göran ^b,d   Anderson, Warwick P ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b MONASH UNIVERSITY   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Angiotensin II; Angiotensin IV; Losartan; LVV hemorphin 7; Renal blood flow

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN II [3-8]; ANGIOTENSIN RECEPTOR; LIGAND; LOSARTAN; LVV HEMORPHIN 7; NEUROPEPTIDE; UNCLASSIFIED DRUG;

ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; HEART RATE; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; RENAL ARTERY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANESTHESIA; ANGIOTENSIN II; ANIMALS; HEMODYNAMIC PROCESSES; HEMOGLOBINS; KIDNEY; LOSARTAN; MALE; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN;

EID: 0032778917     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199908000-00005     Document Type: Article

References (23)

1. Hall JE, Brands MW. Intrarenal and circulating angiotensin II and renal function. In: Robertson JIS, Nicholls MG, eds. The renin-angiotensin system. London: Gower Medical Publishing, 1993:26.1-26.43.
2. Morton JJ. Biochemical aspects of the angiotensins. In: Robertson JIS, Nicholls MG, eds. The renin-angiotensin system. London: Gower Medical Publishing, 1993:9.1-9.12.
3. Wright JW, Krebs LT, Stobb JW, Harding JW. The angiotensin IV system: functional implications. Front Neuroendocrinol 1995;16: 23-52.
4. de Gasparo M, Husain A, Alexander W, et al. Proposed update of angiotensin receptor nomenclature. Hypertension 1995;25:924-7.
5. Lantz I, Glamsta E-L, Talback L, Nyberg F. Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity. FEBS Lett 1991;287:39-41.
6. Moeller I, Lew RA, Mendelsohn FAO, et al. The globin fragment LVV-hemorphin-7 is an endogenous ligand for the AT(4) receptor in the brain. J Neurochem 1997;68:2530-7.
7. Mento PF, Wilkes BM. Plasma angiotensins and blood pressure during converting enzyme inhibition. Hypertension 1987;9(suppl III):III-42-8.
8. Semple PF, Boyd AS, Dawes PM, Morton JJ. Angiotensin II and its heptapeptide (2-8), hexapeptide (3-8), and pentapeptide (4-8) metabolites in arterial and venous blood of man. Circ Res 1976; 39:671-8.
9. Swanson GN, Hanesworth JM, Sardinia MF, et al. Discovery of a distinct binding site for angiotensin II (3-8): a putative angiotensin IV receptor. Regul Peptides 1992;40:409-19.
10. Gardiner SM, Kemp PA, March JE, Bennett T. Regional haemodynamic effects of angiotensin II (3-8) in conscious rats. Br J Pharmacol 1993;110:159-62.
11. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF. Non-peptide angiotensin II receptor antagonists. Trends Pharmacol Sci 1991;12:55-62.
12. Wilkinson L. SYSTAT: the system for statistics. Evanston, IL: SYSTAT Inc., 1990.
13. Ludbrook J. Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res 1994;28:303-11.
14. Coleman JKM, Krebs LT, Hamilton TA, et al. Autoradiographic identification of kidney angiotensin IV binding sites and angiotensin IV-induced renal cortical blood flow changes in rats. Peptides 1998;19:269-77.
15. Champion HC, Garrison EA, Estrada LS, Potter JM, Kadowitz PJ. Analysis of responses to angiotensin I and angiotensin 1-(3-10) in the mesenteric vascular bed of the cat. Eur J Pharmacol 1996;309: 251-9.
16. Campbell DJ, Kladis A. Simultaneous radioimmunoassay of six angiotensin peptides in arterial and venous plasma of man. J Hypertens 1990;8:165-72.
17. Yoshida M, Kikukawa M, Hisa H, Satoh S. Modulation by nitric oxide and prostaglandin of the renal vascular response to angiotensin II (3-8). Br J Pharmacol 1996;117:885-90.
18. 4-receptor system in the rat kidney. Am J Physiol 1998;274:F290-9.
19. 4 receptors: specificity and distribution. Kidney Int 1994; 46:1510-2.
20. Dworkin LD, Brenner BM. The renal circulations. In: Brenner BM, Rector FC Jr, eds. The kidney. Philadelphia: WB Saunders, 1991: 164-204.
21. Riva L, Galzin A-M. Pharmacological characterization of a specific binding site for angiotensin IV in cultured porcine aortic endothelial cells. Eur J Pharmacol 1996;305:193-9.
22. Piot JM, Zhao Q, Guillochon D, Ricart G, Thomas D. Isolation and characterization of two opioid peptides from a bovine hemoglobin peptic hydrolysate. Biochem Biophys Res Commun 1992;189:101-10.
23. Zhao Q, Sannier F, Carreau I, Guillochon D, Piot JM. Inhibition and inhibition kinetics of angiotensin converting enzyme activity by hemorphins, isolated from a peptic bovine hemoglobin hydrolysate. Biochem Biophys Res Commun 1994;204:216-23.